EF Hutton Initiates Coverage On CytoSorbents with Buy Rating, Announces Price Target of $10
Portfolio Pulse from Benzinga Newsdesk
EF Hutton initiates coverage on CytoSorbents (NASDAQ:CTSO) with a Buy rating and sets a price target of $10.
July 29, 2024 | 11:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton has initiated coverage on CytoSorbents with a Buy rating and a price target of $10, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a price target of $10 by EF Hutton is likely to positively impact CytoSorbents' stock price in the short term. Analyst ratings and price targets are significant indicators for investors, and a Buy rating typically suggests confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100